FBInvestor
Stocks / Moonlake Immunotherapeutics
Institutional Ownership

Moonlake Immunotherapeutics

CUSIP 61559X104CLASS A ORDMLTXQ1 2026

Analyst forecast

Analyst recommendation trends (Buy / Hold / Sell consensus) come from a market-data feed. This activates once the forecast feed is connected and this ticker is covered.

Coming soon